Does Left Atrial Appendage Closure (LAAC) provide safe and effective long-term therapy in patients with nonvalvular atrial fibrillation?
Patients with nonvalvular atrial fibrillation
Left Atrial Appendage Closure (LAAC) with the Watchman device
Long-term safety and efficacy (including hemorrhagic stroke rate)safety
Long-term registry data supports LAAC as a safe and effective therapy for patients with nonvalvular atrial fibrillation, highlighting a very low rate of hemorrhagic stroke.
These registries, which contain the longest and largest follow-up data of patients with the Watchman device, support LAAC as a safe and effective therapy for long-term anticoagulation in patients with nonvalvular atrial fibrillation, and document the lowest rate of hemorrhagic stroke identified in this population.
Building similarity graph...
Analyzing shared references across papers
Loading...
Holmes et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69cd9897ee48e5fa6293c3ae — DOI: https://doi.org/10.1016/j.jacc.2019.09.064
David R. Holmes
Vivek Y. Reddy
Nicole Gordon
Journal of the American College of Cardiology
Emory University
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Building similarity graph...
Analyzing shared references across papers
Loading...